Complement activation by candidate biomaterials of an implantable microfabricated medical device

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 98 B, Issue 2, 2011, Pages 323-329

  Sokolov, Andrey ^a   Hellerud, Bernt C ^a   Pharo, Anne ^a   Johannessen, Erik A ^b   Mollnes, Tom E ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF SOUTH EASTERN NORWAY   (Norway)

Author keywords

biocompatibility; complement; immune response; sensor

Indexed keywords

ACTIVATION POTENTIAL; ALUMINIUM OXIDE; BIOLOGICAL SUBSTANCE; CANDIDATE MATERIALS; COMPLEMENT; FLUID-PHASE; HUMAN SERUM; IMMUNE RESPONSE; IMPLANTABLE DEVICES; MATERIAL SURFACE; MEDICAL DEVICES; MICROFABRICATED; NANOPOROUS MEMBRANE; NEGATIVE CONTROL; SOLID-PHASE;

BIOCOMPATIBILITY; BIOMEDICAL ENGINEERING; FLUIDS; GLUCOSE; IMPLANTS (SURGICAL); MICROFABRICATION; SENSORS; SILICONES;

BIOLOGICAL MATERIALS;

ALUMINUM OXIDE; BIOMATERIAL; CELLULOSE; DIMETICONE; POLYAMIDE; POLYCARBONATE; SEALANT;

ARTICLE; BIOCOMPATIBILITY; DEVICE; IMPLANT; LIQUID; MICROTECHNOLOGY; SERUM; SOLID;

BIOCOMPATIBLE MATERIALS; COMPLEMENT ACTIVATION; EQUIPMENT AND SUPPLIES; HUMANS; MATERIALS TESTING; MICROTECHNOLOGY; PROSTHESES AND IMPLANTS;

EID: 79960077484     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31855     Document Type: Article

References (30)

1. Johannessen E, Krushinitskaya O, Sokolov A, Häfliger P, Hoogerwerf A, Hinderling C, Kautio K, Lenkkeri J, Strömmer E, Kondratyev V, et al. Toward an injectable continuous osmotic glucose sensor. J Diabetes Sci Technol 2010; 4: 882-992.
2. Cong P, Ko WH, Young DJ,. Integrated electronic system design for an implantable wireless batteryless blood pressure sensing microsystem. IEEE Sens J 2010; 10: 243-254.
3. Cheney CP, Srijanto B, Hedden DL, Gehl A, Ferrell TL, Schultz J, Engleman EA, McBride WJ, O'Connor S,. In vivo wireless ethanol vapor detection in the Wistar rat. Sens Actuators B Chem 2009; 138: 264-269.
4. Gopalsami N, Osorio I, Kulikov S, Buyko S, Martynov A, Raptis AC,. SAW microsensor brain implant for prediction and monitoring of seizures. IEEE Sens J 2007; 7: 977-982.
5. Meenakshisundaram G, Pandian RP, Eteshola E, Lee SC, Kuppusamy P,. A paramagnetic implant containing lithium naphthalocyanine microcrystals for high-resolution biological oximetry. J Magn Reson 2010; 203: 185-189.
6. 2. Physiol Meas 2004; 25: 421-436. (Pubitemid 38578396)
7. Nevoux J, Loundon N, Leboulanger N, Roger G, Ducou Le PH, Garabedian EN,. Cochlear implant in the carotid canal. Case report and literature review. Int J Pediatr Otorhinolaryngol 2010; 74: 701-703.
8. Tijero M, Gabriel G, Caro J, Altuna A, Hernandez R, Villa R, Berganzo J, Blanco FJ, Salido R, Fernandez LJ,. SU-8 microprobe with microelectrodes for monitoring electrical impedance in living tissues. Biosens Bioelectron 2009; 24: 2410-2416.
9. Oliver NS, Toumazou C, Cass AE, Johnston DG,. Glucose sensors: A review of current and emerging technology. Diabet Med 2009; 26: 197-210.
10. Bloomgarden ZT,. Treatment issues in type 1 diabetes. Diabetes Care 2002; 25: 230-236.
11. Aussedat B, Dupire-Angel M, Gifford R, Klein JC, Wilson GS, Reach G,. Interstitial glucose concentration and glycemia: Implications for continuous subcutaneous glucose monitoring. Am J Physiol Endocrinol Metab 2000; 278: E716-E728. (Pubitemid 30215184)
12. Brauker J,. Continuous glucose sensing: Future technology developments. Diabetes Technol Ther 2009; 11 (Suppl 1): S25-S36.
13. Wisniewski N, Moussy F, Reichert WM,. Characterization of implantable biosensor membrane biofouling. Fresenius J Anal Chem 2000; 366: 611-621.
14. Walport MJ,. Complement. First of two parts. N Engl J Med 2001; 344: 1058-1066.
15. Nilsson B, Ekdahl KN, Mollnes TE, Lambris JD,. The role of complement in biomaterial-induced inflammation. Mol Immunol 2007; 44: 82-94. (Pubitemid 44647107)
16. Janatova J, Cheung AK, Parker CJ,. Biomedical polymers differ in their capacity to activate complement. Complement Inflamm 1991; 8: 61-69.
17. Andersson J, Ekdahl KN, Lambris JD, Nilsson B,. Binding of C3 fragments on top of adsorbed plasma proteins during complement activation on a model biomaterial surface. Biomaterials 2005; 26: 1477-1485. (Pubitemid 39441380)
18. Lhotta K, Wurzner R, Kronenberg F, Oppermann M, Konig P,. Rapid activation of the complement system by cuprophane depends on complement component C4. Kidney Int 1998; 53: 1044-1051. (Pubitemid 28155682)
19. Mollnes TE, Lea T, Harboe M, Tschopp J,. Monoclonal antibodies recognizing a neoantigen of poly(C9) detect the human terminal complement complex in tissue and plasma. Scand J Immunol 1985; 22: 183-195. (Pubitemid 15016793)
20. Garred P, Mollnes TE, Lea T, Fischer E,. Characterization of a monoclonal antibody MoAb bH6 reacting with a neoepitope of human C3 expressed on C3b, iC3b, and C3c. Scand J Immunol 1988; 27: 319-327. (Pubitemid 18076756)
21. Mollnes TE, Lea T, Froland SS, Harboe M,. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex. Scand J Immunol 1985; 22: 197-202. (Pubitemid 15016794)
22. Mollnes TE, Redl H, Hogasen K, Bengtsson A, Garred P, Speilberg L, Lea T, Oppermann M, Gotze O, Schlag G,. Complement activation in septic baboons detected by neoepitope-specific assays for C3b/iC3b/C3c, C5a and the terminal C5b-9 complement complex (TCC). Clin Exp Immunol 1993; 91: 295-300. (Pubitemid 23045677)
23. Andersson J, Ekdahl KN, Larsson R, Nilsson UR, Nilsson B,. C3 adsorbed to a polymer surface can form an initiating alternative pathway convertase. J Immunol 2002; 168: 5786-5791. (Pubitemid 34556164)
24. Mollnes TE, Riesenfeld J, Garred P, Nordstrom E, Hogasen K, Fosse E, Gotze O, Harboe M,. A new model for evaluation of biocompatibility: Combined determination of neoepitopes in blood and on artificial surfaces demonstrates reduced complement activation by immobilization of heparin. Artif Organs 1995; 19: 909-917.
25. Ferraz N, Nilsson B, Hong J, Karlsson OM,. Nanoporesize affects complement activation. J Biomed Mater Res A 2008; 87: 575-581.
26. Lappegard KT, Fung M, Bergseth G, Riesenfeld J, Lambris JD, Videm V, Mollnes TE,. Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation. Ann Thorac Surg 2004; 77: 932-941. (Pubitemid 38271064)
27. Nilsson UR, Larm O, Nilsson B, Storm KE, Elwing H, Nilsson EK,. Modification of the complement binding properties of polystyrene: Effects of end-point heparin attachment. Scand J Immunol 1993; 37: 349-354. (Pubitemid 23070511)
28. Andersson J, Larsson R, Richter R, Ekdahl KN, Nilsson B,. Binding of a model regulator of complement activation (RCA) to a biomaterial surface: Surface-bound factor H inhibits complement activation. Biomaterials 2001; 22: 2435-2443. (Pubitemid 32666235)
29. Olsson P, Sanchez J, Mollnes TE, Riesenfeld J,. On the blood compatibility of end-point immobilized heparin. J Biomater Sci Polym Ed 2000; 11: 1261-1273. (Pubitemid 32208308)
30. Bexborn F, Engberg AE, Sandholm K, Mollnes TE, Hong J, Nilsson EK,. Hirudin versus heparin for use in whole blood in vitro biocompatibility models. J Biomed Mater Res A 2009; 89: 951-959.